Anne S. Tsao, MD
Medical oncologist and thoracic cancer expert with clinical and academic focus on immunotherapy and translational research in thoracic malignancies; provides overview of PD-1/CTLA-4 bispecific antibodies and related clinical trials in the episode.
Best podcasts with Anne S. Tsao, MD
Ranked by the Snipd community
Feb 26, 2026 • 28min
S16 Ep11: Expert Illustrations & Commentaries: Translating the Science of Bispecific Antibodies in Solid Tumors – From Mechanisms to Emerging Data
John V. Heymach, MD, PhD, a thoracic oncology physician-scientist, and Anne S. Tsao, MD, MBA, a medical oncologist focused on thoracic immunotherapy, discuss bispecific antibodies. They cover PD-1/CTLA-4 platforms, VEGF–PD-1 mechanisms and trial data, and DLL3-directed T-cell engagers like tarlatimab. Conversation also touches on safety management and potential roles in thoracic cancers.
